Axonics Modulation Technologies Inc (AXNX)

NASDAQ
73.27
+1.95(+2.73%)
  • Volume:
    185,181
  • Bid/Ask:
    73.08/73.23
  • Day's Range:
    71.14 - 73.27
  • Type:Equity
  • Market:United States
  • ISIN:US05465P1012
  • CUSIP:00005465P101

AXNX Overview

Prev. Close
71.32
Day's Range
71.14-73.27
Revenue
150.26M
Open
71.91
52 wk Range
40.05-79.81
EPS
-1.68
Volume
185,181
Market Cap
3.29B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
517,137
P/E Ratio
-
Beta
-
1-Year Change
71.01%
Shares Outstanding
46,090,964
Next Earnings Date
Dec 14, 2021
What is your sentiment on Axonics Modulation Technologies Inc?
or
Vote to see community's results!

Axonics Modulation Technologies Inc News

Axonics Modulation Technologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy

Axonics Modulation Technologies Inc Company Profile

Axonics Modulation Technologies Inc Company Profile

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company’s SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.